haloperidol has been researched along with kf 17837s in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kanda, T; Nakamura, J; Shimada, J; Shiozaki, S; Suzuki, F | 1 |
Betz, A; Correa, M; Dobson, DR; O'Neill, MF; O'Neill, MJ; Salamone, JD; Wisniecki, A | 1 |
2 other study(ies) available for haloperidol and kf 17837s
Article | Year |
---|---|
KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity.
Topics: Adenosine; Administration, Oral; Animals; Antihypertensive Agents; Benserazide; Catalepsy; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Levodopa; Male; Mice; Phenethylamines; Purinergic Antagonists; Xanthines | 1994 |
The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism.
Topics: Adenosine A2 Receptor Antagonists; Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Inhibition, Psychological; Jaw; Male; Motor Activity; Movement; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Tremor; Xanthines | 2004 |